94 related articles for article (PubMed ID: 8076384)
1. New serum markers for small-cell lung cancer. I. The ganglioside fucosyl-GM1.
Vangsted A; Drivsholm L; Andersen E; Pallesen T; Zeuthen J; Wallin H
Cancer Detect Prev; 1994; 18(3):221-9. PubMed ID: 8076384
[TBL] [Abstract][Full Text] [Related]
2. New serum markers for small-cell lung cancer. II. The neural cell adhesion molecule, NCAM.
Vangsted A; Drivsholm L; Andersen E; Bock E
Cancer Detect Prev; 1994; 18(4):291-8. PubMed ID: 7982239
[TBL] [Abstract][Full Text] [Related]
3. Immunochemical detection of a small cell lung cancer-associated ganglioside (FucGM1) antigen in serum.
Vangsted AJ; Clausen H; Kjeldsen TB; White T; Sweeney B; Hakomori S; Drivsholm L; Zeuthen J
Cancer Res; 1991 Jun; 51(11):2879-84. PubMed ID: 1851663
[TBL] [Abstract][Full Text] [Related]
4. Fucosyl-GM1 in small-cell lung cancer. A comparison with the tumour marker neuron-specific enolase.
Drivsholm L; Vangsted A; Pallesen T; Hansen M; Dombernowsky P; Hirsch F; Hansen HH
Ann Oncol; 1994 Sep; 5(7):623-6. PubMed ID: 7993838
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies for diagnosis and potential therapy of small cell lung cancer--the ganglioside antigen fucosyl-GM1.
Vangsted AJ; Zeuthen J
Acta Oncol; 1993; 32(7-8):845-51. PubMed ID: 8305235
[TBL] [Abstract][Full Text] [Related]
6. Serum immunoassay of a small cell lung cancer associated ganglioside: development of a sensitive scintillation proximity assay.
Pallesen T; Vangsted A; Drivsholm L; Clausen H; Zeuthen J; Wallin H
Glycoconj J; 1992 Dec; 9(6):331-5. PubMed ID: 1339041
[TBL] [Abstract][Full Text] [Related]
7. Small cell lung cancer is not associated with the presence of anti-fucosyl-GM1 ganglioside autoantibodies reactive in immunoenzymatic test.
Adler G; Pacuszka T; Lewartowska A; Rowinska E; Oblakowski P; Panasiewicz M
Lung Cancer; 2001 Dec; 34(3):383-5. PubMed ID: 11714535
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer.
Dickler MN; Ragupathi G; Liu NX; Musselli C; Martino DJ; Miller VA; Kris MG; Brezicka FT; Livingston PO; Grant SC
Clin Cancer Res; 1999 Oct; 5(10):2773-9. PubMed ID: 10537341
[TBL] [Abstract][Full Text] [Related]
9. Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin.
Krug LM; Ragupathi G; Hood C; Kris MG; Miller VA; Allen JR; Keding SJ; Danishefsky SJ; Gomez J; Tyson L; Pizzo B; Baez V; Livingston PO
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6094-100. PubMed ID: 15447995
[TBL] [Abstract][Full Text] [Related]
10. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
[TBL] [Abstract][Full Text] [Related]
11. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.
Milman N; Pedersen LM
Oncol Rep; 2002; 9(1):193-8. PubMed ID: 11748482
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of ProGRP31-98 in patients with small-cell lung cancer].
Yang J; Li R; Li A
Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):216-8. PubMed ID: 11778234
[TBL] [Abstract][Full Text] [Related]
13. CEA is an independent prognostic indicator that is associated with reduced survival and liver metastases in SCLC.
Yang X; Wang D; Yang Z; Qing Y; Zhang Z; Wang G; Yang Z; Wang Z
Cell Biochem Biophys; 2011 Mar; 59(2):113-9. PubMed ID: 20945115
[TBL] [Abstract][Full Text] [Related]
14. [The use of monoclonal antibodies in the detection of small cell lung cancer metastases in bone marrow].
Obłakowski P; Pacuszka T; Rogińska E; Remiszewski P; Załeska J; Zych J; Roszkowski K; Rowińska-Zakrzewska E
Pneumonol Alergol Pol; 1999; 67(1-2):53-9. PubMed ID: 10481525
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
[TBL] [Abstract][Full Text] [Related]
16. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) detection in cancer patients: a prognostic marker for lung metastases from solid malignancies.
Karapanagiotou EM; Pelekanou E; Charpidou A; Tsaganos T; Anagnostou V; Plachouras D; Giamarellos-Bourboulis EJ; Syrigos KN
Anticancer Res; 2008; 28(2B):1411-5. PubMed ID: 18505088
[TBL] [Abstract][Full Text] [Related]
17. A Novel, Fully Human Anti-fucosyl-GM1 Antibody Demonstrates Potent
Ponath P; Menezes D; Pan C; Chen B; Oyasu M; Strachan D; LeBlanc H; Sun H; Wang XT; Rangan VS; Deshpande S; Cristea S; Park KS; Sage J; Cardarelli PM
Clin Cancer Res; 2018 Oct; 24(20):5178-5189. PubMed ID: 30021910
[No Abstract] [Full Text] [Related]
18. [Prognostic factors in patients with small cell lung cancer].
Song LH; Song XR; Zhang XQ; Qi JL; Li XJ; Tian H; Bu B
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):413-6. PubMed ID: 15355646
[TBL] [Abstract][Full Text] [Related]
19. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA.
Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H
Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150
[TBL] [Abstract][Full Text] [Related]
20. Genetic mechanisms for the synthesis of fucosyl GM1 in small cell lung cancer cell lines.
Tokuda N; Zhang Q; Yoshida S; Kusunoki S; Urano T; Furukawa K; Furukawa K
Glycobiology; 2006 Oct; 16(10):916-25. PubMed ID: 16880505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]